ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測

Polyhydroxyalkanoate (PHA) Market - Global Forecast To 2030

Polyhydroxyalkanoate (PHA) Market by Type (Short Chain Length, Medium Chain Length), Production Method (Sugar Fermentation, Vegetable Oil Fermentation), Application (Packaging & Food Services, Biomedical), and Region - Global Forecasts to 2030

商品番号 : SMB-19273

出版社MarketsandMarkets
出版年月2025年12月
ページ数225
図表数273
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

ポリヒドロキシアルカノエート(PHA)市場 – タイプ(短鎖長、中鎖長)、製造方法(糖発酵、植物油発酵)、用途(包装・食品サービス、バイオメディカル)、地域別 – 2030年までの世界予測

ポリヒドロキシアルカノエート(PHA)市場規模は2025年には1億2,380万米ドルで、2025年から2030年の間に16.5%のCAGRで成長し、2030年には2億6,520万米ドルに達すると予測されています。

調査対象範囲

本レポートでは、ポリヒドロキシアルカノエート(PHA)市場を種類、製造方法、用途、地域に基づいてセグメント化し、様々な地域における市場全体の推定価値(百万米ドル)を示しています。主要業界プレーヤーの詳細な分析を実施し、PHA市場に関連する各社の事業概要、サービス、主要戦略に関する洞察を提供しています。

このレポートを購入する理由

この調査レポートは、業界分析(業界動向)、主要企業の市場シェア分析、企業プロファイルといった様々なレベルの分析に焦点を当てており、これらを組み合わせることで、競争環境、PHA市場における新興・高成長セグメント、高成長地域、市場牽引要因、制約要因、機会に関する全体像を把握できます。

本レポートでは、以下の点について洞察を提供しています。

  • 市場浸透:世界市場の主要企業が提供するPHAに関する包括的な情報
  • PHA市場の成長に影響を与える主要な推進要因(グリーン調達政策、再生可能で費用対効果の高い原材料の豊富な供給、生分解性による消費の促進、人の健康と安全への懸念の高まり)、制約要因(従来のポリマーと比較して価格が高いこと、性能上の問題)、機会(最終用途セグメントの範囲拡大、新規原材料の出現、コスト削減を可能にするシアノバクテリア、アジア太平洋地域における成長機会)、課題(初期段階の製造技術、高価で複雑な製造プロセス)の分析
  • 製品開発/イノベーション:ポリヒドロキシアルカノエート(PHA)市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細な洞察
  • 市場開発:成長著しい新興市場に関する包括的な情報。本レポートでは、地域をまたいでPHA市場を分析しています。
  • 市場多様化:新製品、未開拓地域、世界のポリヒドロキシアルカノエート(PHA)市場における最近の動向に関する包括的な情報
  • 競合評価:PHA市場における主要企業の市場シェア、戦略、製品、製造能力に関する詳細な評価

Report Description

The polyhydroxyalkanoate (PHA) market size was USD 123.8 million in 2025 and is projected to reach USD 265.2 million by 2030, at a CAGR of 16.5% between 2025 and 2030.

ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測
Polyhydroxyalkanoate (PHA) Market – Global Forecast To 2030

“Regulatory pressure and sustainability mandates to accelerate PHA market growth”

Strict global policies against plastic waste and the use of fossil-based substances are a major driver of the PHA market. Governments are also taking actions such as banning single-use plastic, encouraging bio-based polymers, and making compostability mandatory, which provide a regulatory push towards PHAs. Such policies have been especially significant in areas like packaging, consumer goods, agriculture, and biomedical applications, where adherence to environmental and safety standards is becoming a prerequisite. Brands are being pressurized to enhance sustainability activities and are compelled to implement PHAs to achieve corporate ESG goals. These regulatory and corporate sustainability requirements are providing a boost to the transition to PHA-based solutions in industries.

“Agriculture sector to account for third-largest market share during forecast period“

In 2024, the agriculture sector accounted for the third-largest share in the overall PHA market. The increase in demand for biodegradable and soil-safe materials in agricultural activities is driving the market in this application. As there is an ongoing shift toward sustainability and regulatory standards, PHA is being implemented in mulch films, plant pots, seed coatings, and controlled-release fertilizers by manufacturers who are avoiding the use of conventional plastics. Its biodegradation in soil saves waste-management expense and reduces environmental impact. Moreover, government incentives for the use of environmentally friendly farm inputs also speed up adoption.

“Short chain length segment projected to be fastest-growing type of PHA during forecast period”

The short chain length PHA segment is estimated to be the fastest-growing type, in terms of value, during the forecast period.  Short chain length PHA is more mechanically strong, more crystalline, and applicable in a wide range of packaging, agriculture, and biomedical products. Its performance properties resemble traditional plastics and, hence, is a suitable alternative in industries that are rapidly moving towards biodegradable products. The intense regulatory pressure to minimize the consumption of fossil-based plastics further boosts the demand for short chain length PHA. Moreover, the expansion of production capacities and enhancement of cost structures are facilitating increased commercial usage.

ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 - 地域
Polyhydroxyalkanoate (PHA) Market – Global Forecast To 2030 – region

“Asia Pacific accounted for third-largest share of global PHA market, in terms of value, in 2024”

Asia Pacific is the third-largest PHA market in 2024.  The market in the region is driven by the increase in demand for biodegradable materials in the packaging, agriculture, and consumer goods applications. Increasing regulatory intervention with single-use plastics in China, Japan, India, and South Korea is creating a motivating push towards PHA-based products. The region’s market is also supported by a growing biopolymer production base and a high level of government attention toward the circular economy. The growing consumer interest in sustainable materials, as well as the booming development of e-commerce packaging, further supports the market growth.

  • By Company Type: Tier 1 – 55%, Tier 2 – 25%, and Tier 3 – 20%
  • By Designation: Directors – 50%, Managers – 30%, and Others – 20%
  • By Region: North America – 40%, Europe – 35%, Asia Pacific – 20%, RoW– 5%
ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 - 対象企業
Polyhydroxyalkanoate (PHA) Market – Global Forecast To 2030 – ecosystem

The key players profiled in the report include Teknor Apex (US), Kaneka Corporation (Japan), Ecomann Biotechnology Co., Ltd. (China), RWDC Industries (Singapore), Bluepha Co., Ltd. (China), Newlight Technologies, Inc. (US), Ningbo Tianan Biologic Materials Co., Ltd. (China), Biomer (Germany), Beijing PhaBuilder Biotechnology Co., Ltd. (China), and TerraVerdae Bioworks Inc. (Canada).

Study Coverage

This report segments the market for PHA based on type, production method, application, and region, and provides estimations of value (in USD Million) for the overall market size across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, services, and key strategies associated with the PHA market.

Reasons to Buy this Report

This research report is focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the PHA market, high-growth regions, and market drivers, restraints, and opportunities.

The report provides insights into the following points:

  • Market Penetration: Comprehensive information on PHA offered by top players in the global market
  • Analysis of key drivers: (Green procurement policies, High availability of renewable and cost-effective raw materials, Biodegradability driving consumption, Increasing concerns about human health and safety), restraints (High price compared to conventional polymers and Performance issues), opportunities (Increasing scope in end-use segments, Emergence of new raw materials, Cyanobacteria enabling cost reduction, and Growth opportunities in Asia Pacific) and challenges (Manufacturing technology in initial phase and Expensive and complex production process) influencing the growth of PHA market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the PHA market
  • Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the market for PHA across regions.
  • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global PHA market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the PHA market

Table of Contents

1               INTRODUCTION              22

1.1           STUDY OBJECTIVES       22

1.2           MARKET DEFINITION   22

1.3           STUDY SCOPE   23

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      23

1.3.2        INCLUSIONS AND EXCLUSIONS OF STUDY          23

1.3.3        MARKET DEFINITION AND INCLUSIONS, BY TYPE                 24

1.3.4        MARKET DEFINITION AND INCLUSIONS, BY PRODUCTION METHOD               24

1.3.5        MARKET DEFINITION AND INCLUSIONS, BY APPLICATION   24

1.3.6        YEARS CONSIDERED      25

1.3.7        CURRENCY CONSIDERED            25

1.3.8        UNIT CONSIDERED        25

1.4           STAKEHOLDERS               25

1.5           SUMMARY OF CHANGES               26

2               EXECUTIVE SUMMARY  27

2.1           KEY INSIGHTS AND MARKET HIGHLIGHTS          27

2.2           KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS    29

2.3           DISRUPTIVE TRENDS SHAPING MARKET               30

2.4           HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS                 30

2.5           SNAPSHOT: EUROPE MARKET SIZE, GROWTH RATE, AND FORECAST                31

3               PREMIUM INSIGHTS       33

3.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHA MARKET               33

3.2           PHA MARKET, BY APPLICATION AND REGION   34

3.3           PHA MARKET, BY TYPE 34

3.4           PHA MARKET, BY COUNTRY       35

4               MARKET OVERVIEW       36

4.1           INTRODUCTION              36

4.2           MARKET DYNAMICS       36

4.2.1        DRIVERS               37

4.2.1.1    Green procurement policies                37

4.2.1.2    High availability of renewable and cost-effective raw materials                 38

4.2.1.3    Biodegradability driving consumption              39

4.2.1.4    Increasing concerns about human health and safety       39

4.2.2        RESTRAINTS      42

4.2.2.1    Higher price of PHA than conventional polymers          42

4.2.2.2    Performance issues               42

4.2.3        OPPORTUNITIES              42

4.2.3.1    Increasing scope in end-use segments               42

4.2.3.2    Emergence of new raw materials       43

4.2.3.3    Cyanobacteria enabling cost reduction             43

4.2.3.4    Growth opportunities in Asia Pacific                 43

4.2.4        CHALLENGES    44

4.2.4.1    Manufacturing technology in initial phase       44

4.2.4.2    Expensive and complex production process     44

4.3           INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES              44

4.3.1        INTERCONNECTED MARKETS   44

4.3.2        CROSS-SECTOR OPPORTUNITIES             45

4.4           STRATEGIC MOVES BY TIER-1/2/3 PLAYERS        45

4.4.1        KEY MOVES AND STRATEGIC FOCUS      45

5               INDUSTRY TRENDS         46

5.1           PORTER’S FIVE FORCES ANALYSIS            46

5.1.1        THREAT OF SUBSTITUTES          46

5.1.2        THREAT OF NEW ENTRANTS      47

5.1.3        BARGAINING POWER OF SUPPLIERS       47

5.1.4        BARGAINING POWER OF BUYERS             47

5.1.5        INTENSITY OF COMPETITIVE RIVALRY 47

5.2           MACROECONOMIC INDICATORS              48

5.2.1        INTRODUCTION              48

5.2.2        GDP TRENDS AND FORECAST FOR MAJOR ECONOMIES                 48

5.2.3        TRENDS IN GLOBAL PACKAGING INDUSTRY      50

5.3           SUPPLY CHAIN ANALYSIS             50

5.4           ECOSYSTEM ANALYSIS  52

5.5           PRICING ANALYSIS          55

5.5.1        AVERAGE SELLING PRICE OF PHA OFFERED BY KEY PLAYERS,

BY APPLICATION, 2024  55

5.5.2        AVERAGE SELLING PRICE TREND OF PHA, BY REGION, 2022–2025              56

5.6           TRADE ANALYSIS             56

5.6.1        IMPORT SCENARIO (HS CODE 391190)    57

5.6.2        EXPORT SCENARIO (HS CODE 391190)    58

5.7           KEY CONFERENCES & EVENTS IN 2025–2026          59

5.8           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       59

5.9           INVESTMENT AND FUNDING SCENARIO               60

5.10         CASE STUDY ANALYSIS 61

5.10.1      BACARDI TRANSITIONS FROM PET TO DANIMER SCIENTIFIC’S BIODEGRADABLE PHA BOTTLES FOR SUSTAINABLE PACKAGING         61

5.10.2      SHISEIDO COMPANY LTD. ADOPTS PHBH BIOPOLYMER FOR

COSMETICS PACKAGING              61

5.11         IMPACT OF 2025 US TARIFF – PHA MARKET         61

5.11.1      INTRODUCTION              61

5.11.2      KEY TARIFF RATES          62

5.11.3      PRICE IMPACT ANALYSIS             63

5.11.4      IMPACT ON COUNTRY/REGION                63

5.11.4.1  US           63

5.11.4.2  Europe   64

5.11.4.3  Asia Pacific            64

5.11.5      IMPACT ON APPLICATIONS        65

6               TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, AND PATENTS                67

6.1           KEY EMERGING TECHNOLOGIES              67

6.1.1        SYNTHETIC BIOLOGY AND STRAIN ENGINEERING                 67

6.1.2        CONTINUOUS AND HIGH-DENSITY BIOREACTORS                 67

6.1.3        PHA BLENDS AND COPOLYMERS              67

6.2           COMPLEMENTARY TECHNOLOGIES       68

6.2.1        DOWNSTREAM PURIFICATION TECHNOLOGIES                 68

6.2.2        COMPOSTING & BIODEGRADATION TECHNOLOGIES                 68

6.3           TECHNOLOGY/PRODUCT ROADMAP    68

6.3.1        SHORT-TERM (2025–2027) | PRODUCTION SCALE-UP & COST REDUCTION          68

6.3.2        MID-TERM (2027–2030) | PERFORMANCE ENHANCEMENT & APPLICATION EXPANSION    69

6.3.3        LONG-TERM (2030–2035+) | SUSTAINABILITY & CIRCULARITY    69

6.4           PATENT ANALYSIS          70

6.4.1        APPROACH         70

6.4.2        DOCUMENT TYPE           70

6.4.3        TOP APPLICANTS            73

6.4.4        JURISDICTION ANALYSIS              75

6.5           IMPACT OF AI/GEN AI ON PHA MARKET                75

6.5.1        ACCELERATED R&D AND FORMULATION INNOVATION                 76

6.5.2        ENHANCED PRODUCTION EFFICIENCY AND PROCESS CONTROL            76

6.5.3        PREDICTIVE MAINTENANCE AND OPERATIONAL CONTINUITY     76

6.5.4        OPTIMIZED SUPPLY CHAIN AND COST MANAGEMENT                 76

6.5.5        SUSTAINABILITY MODELING AND LIFE CYCLE OPTIMIZATION                76

7               SUSTAINABILITY AND REGULATORY LANDSCAPE                 77

7.1           REGIONAL REGULATIONS AND COMPLIANCE   77

7.1.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             77

7.1.2        INDUSTRY STANDARDS                79

7.2           SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES       80

7.2.1        SAFETY PROTOCOLS      80

7.2.2        SUSTAINABLE DEVELOPMENT 80

7.2.3        STANDARDIZATION       80

7.2.4        CIRCULAR ECONOMY    80

7.3           CERTIFICATIONS, LABELING, AND ECO-STANDARDS                 81

8               CUSTOMER LANDSCAPE & BUYER BEHAVIOR    82

8.1           DECISION-MAKING PROCESS     82

8.2           KEY STAKEHOLDERS AND BUYING CRITERIA     83

8.2.1        KEY STAKEHOLDERS IN BUYING PROCESS           83

8.2.2        BUYING CRITERIA           83

8.3           ADOPTION BARRIERS & INTERNAL CHALLENGES                 84

8.4           UNMET NEEDS IN VARIOUS APPLICATIONS        85

9               SOURCES AND PROCESSES OF PHA PRODUCTION                 87

9.1           GENERAL PRODUCTION PROCESS           87

9.2           SUGAR SUBSTRATE OR CARBOHYDRATES FROM PLANTS                87

9.3           TRIACYLGLYCEROLS      88

9.4           HYDROCARBONS             89

9.5           STRAIN SELECTION        89

9.6           BIOPROCESS AND DOWNSTREAM PROCESS        91

9.6.1        FERMENTATION PROCESS           91

9.6.1.1    Discontinuous process         91

9.6.1.1.1 Batch process        91

9.6.1.1.2 Fed-batch process 91

9.6.1.1.3 Fed-batch process with cell recycling                91

9.6.1.1.4 Repeated fed-batch              91

9.6.1.2    Continuous process              91

9.6.1.2.1 Continuous fed-batch process            91

9.6.1.2.2 One-stage chemostat           92

9.6.1.2.3 Two-stage chemostat           92

9.6.1.2.4 Multi-stage chemostat         92

9.6.2        EXTRACTION PROCESS 92

10            PRODUCTION CAPACITY ANALYSIS        93

11            PHA MARKET, BY TYPE 96

11.1         INTRODUCTION              97

11.2         SHORT CHAIN LENGTH                 99

11.2.1      EXCELLENT PHYSICAL AND MECHANICAL PROPERTIES TO DRIVE MARKET         99

11.2.2      POLYHYDROXYVALERATE (PHV)              99

11.2.3      P (4HB-CO-3HB)                99

11.2.4      P (3HB-CO-3HV)                99

11.2.5      OTHERS                99

11.3         MEDIUM CHAIN LENGTH             101

11.3.1      EXPANDING APPLICATION NEEDS IN BIOMEDICAL AND PACKAGING SECTORS PROPEL MARKET GROWTH          101

11.3.2      P (HYDROXYBUTYRATE-CO-HYDROXYOCTANOATE)                 101

11.3.3      P (3HB-CO-3HV-CO-4HB)              101

11.3.4      OTHERS                101

12            PHA MARKET, BY PRODUCTION METHOD           103

12.1         INTRODUCTION              104

12.2         SUGAR FERMENTATION               105

12.2.1      AVAILABILITY OF LOW-COST CARBOHYDRATE FEEDSTOCKS

TO BOOST DEMAND      105

12.3         VEGETABLE OIL FERMENTATION            106

12.3.1      STRENGTHENING CIRCULAR ECONOMY POLICIES ACCELERATING

MARKET ADOPTION      106

12.4         METHANE FERMENTATION        106

12.4.1      EXPANDING WASTE-GAS UTILIZATION AND CARBON-REDUCTION

MANDATES ACCELERATING MARKET GROWTH                106

13            PHA MARKET, BY APPLICATION                107

13.1         INTRODUCTION              108

13.2         PACKAGING & FOOD SERVICES 110

13.2.1      PACKAGING       110

13.2.1.1  Rigid packaging    110

13.2.1.1.1                High durability, tamper-resistance, lightweight, and

low cost, to drive market     110

13.2.1.2  Flexible packaging                110

13.2.1.2.1                Replacement for petroleum-based plastics to drive market    110

13.2.1.3  Other packaging   111

13.2.2      FOOD SERVICES               111

13.2.2.1  Cups       111

13.2.2.1.1                Increasing use of biodegradable disposable products

to drive market      111

13.2.2.2  Trays      111

13.2.2.2.1                Increasing demand for sustainable trays to drive market                 111

13.2.2.3  Other food services              111

13.3         BIOMEDICAL     113

13.3.1      SUTURES             113

13.3.1.1  High tensile strength to drive market                113

13.3.2      DRUG RELEASE 113

13.3.2.1  Biocompatibility for drug carrier applications to drive market                 113

13.3.3      OTHER BIOMEDICAL APPLICATIONS     114

13.4         AGRICULTURE  115

13.4.1      MULCH FILMS   115

13.4.1.1  Extensive use by farmers to drive market         115

13.4.2      PLANT POTS      115

13.4.2.1  Plant pots help during stages of plant growth 115

13.4.3      OTHER AGRICULTURAL APPLICATIONS               115

13.5         OTHER APPLICATIONS 117

13.5.1      WASTEWATER TREATMENT       117

13.5.2      COSMETICS        117

13.5.3      CHEMICAL ADDITIVES 117

13.5.4      3D PRINTING     117

14            PHA MARKET, BY REGION            120

14.1         INTRODUCTION              121

14.2         EUROPE               123

14.2.1      GERMANY           128

14.2.1.1  Advanced infrastructure for solid waste management to drive market    128

14.2.2      UK          128

14.2.2.1  Government’s aim to achieve zero-waste economy to drive market    128

14.2.3      FRANCE                129

14.2.3.1  Government’s initiatives for bio-based economy to drive market                 129

14.2.4      ITALY    130

14.2.4.1  Demand for eco-friendly packaging solutions to drive market                 130

14.3         NORTH AMERICA             131

14.3.1      US           135

14.3.1.1  Stringent guidelines regarding production, use, and disposal of plastics to drive market        135

14.3.2      CANADA               136

14.3.2.1  Proposed ban on single-use plastics to drive market      136

14.3.3      MEXICO                137

14.3.3.1  Government initiatives and international investments to drive market    137

14.4         ASIA PACIFIC     138

14.4.1      CHINA  142

14.4.1.1  Global and local PHA manufacturers to drive market    142

14.4.2      INDIA    143

14.4.2.1  Ban on non-biodegradable plastics to drive market        143

14.4.3      JAPAN   144

14.4.3.1  Biomass-based and biodegradable plastics to drive market                 144

14.4.4      MALAYSIA           145

14.4.4.1  Fully automated biodegradable plastic from palm oil to drive market    145

14.4.5      SOUTH KOREA  145

14.4.5.1  High number of R&D establishments to drive market   145

14.5         REST OF THE WORLD    146

14.5.1      SOUTH AMERICA             150

14.5.1.1  Awareness of green economy to drive market 150

14.5.2      MIDDLE EAST & AFRICA                150

14.5.2.1  Growing biomedical industry to drive market 150

15            COMPETITIVE LANDSCAPE         152

15.1         INTRODUCTION              152

15.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            152

15.3         MARKET SHARE ANALYSIS, 2024                 154

15.4         REVENUE ANALYSIS, 2020–2024  156

15.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 157

15.5.1      STARS   157

15.5.2      EMERGING LEADERS     157

15.5.3      PERVASIVE PLAYERS      157

15.5.4      PARTICIPANTS 157

15.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         159

15.5.5.1  Company footprint               159

15.5.5.2  Region footprint   160

15.5.5.3  Type footprint       161

15.5.5.4  Application footprint            162

15.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        163

15.6.1      PROGRESSIVE COMPANIES         163

15.6.2      RESPONSIVE COMPANIES            163

15.6.3      DYNAMIC COMPANIES  163

15.6.4      STARTING BLOCKS         163

15.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 164

15.6.5.1  Detailed list of key startups/SMEs    164

15.6.5.2  Competitive benchmarking of key startups/SMEs          165

15.7         BRAND COMPARISON ANALYSIS               165

15.8         COMPANY VALUATION AND FINANCIAL METRICS                 166

15.9         COMPETITIVE SCENARIO             167

15.9.1      PRODUCT LAUNCHES   167

15.9.2      DEALS  168

15.9.3      EXPANSIONS     171

15.9.4      OTHER DEVELOPMENTS              172

16            `COMPANY PROFILES   173

16.1         KEY PLAYERS     173

16.1.1      TEKNOR APEX   173

16.1.1.1  Business overview 173

16.1.1.2  Products/Solutions/Services offered 173

16.1.1.3  Recent developments           174

16.1.1.3.1                Deals      174

16.1.1.4  MnM view              174

16.1.1.4.1                Key strengths        174

16.1.1.4.2                Strategic choices   174

16.1.1.4.3                Weaknesses and competitive threats 174

16.1.2      KANEKA CORPORATION               175

16.1.2.1  Business overview 175

16.1.2.2  Products/Solutions/Services offered 176

16.1.2.3  Recent developments           177

16.1.2.3.1                Deals      177

16.1.2.3.2                Expansions             177

16.1.2.4  MnM view              177

16.1.2.4.1                Key strengths        177

16.1.2.4.2                Strategic choices   178

16.1.2.4.3                Weaknesses and competitive threats 178

16.1.3      ECOMANN BIOTECHNOLOGY CO. LTD 179

16.1.3.1  Business overview 179

16.1.3.2  Products/Solutions/Services offered 179

16.1.3.3  MnM view              180

16.1.3.3.1                Right to win           180

16.1.3.3.2                Strategic choices   180

16.1.3.3.3                Weaknesses and competitive threats 180

16.1.4      RWDC INDUSTRIES         181

16.1.4.1  Business overview 181

16.1.4.2  Products/Solutions/Services offered 181

16.1.4.3  Recent developments           181

16.1.4.3.1                Deals      181

16.1.4.3.2                Other developments             182

16.1.4.4  MnM view              183

16.1.4.4.1                Key strengths        183

16.1.4.4.2                Strategic choices   183

16.1.4.4.3                Weaknesses and competitive threats 183

16.1.5      BLUEPHA CO, LTD.         184

16.1.5.1  Business overview 184

16.1.5.2  Products/Solutions/Services offered 184

16.1.5.3  Recent developments           185

16.1.5.3.1                Product launches  185

16.1.5.3.2                Deals      185

16.1.5.3.3                Expansions             186

16.1.5.4  MnM view              186

16.1.5.4.1                Key strengths        186

16.1.5.4.2                Strategic choices   186

16.1.5.4.3                Weaknesses and competitive threats 186

16.1.6      NEWLIGHT TECHNOLOGIES, INC.            187

16.1.6.1  Business overview 187

16.1.6.2  Products/Solutions/Services offered 187

16.1.6.3  Recent developments           187

16.1.6.3.1                Deals      187

16.1.6.3.2                Expansions             188

16.1.6.4  MnM view              189

16.1.6.4.1                Key strengths        189

16.1.6.4.2                Strategic choices   189

16.1.6.4.3                Weaknesses and competitive threats 189

16.1.7      NINGBO TIANAN BIOMATERIALS CO., LTD.         190

16.1.7.1  Business overview 190

16.1.7.2  Products/Solutions/Services offered 190

16.1.8      BIOMER                191

16.1.8.1  Business overview 191

16.1.8.2  Products/Solutions/Services offered 191

16.1.9      BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD                 192

16.1.9.1  Business overview 192

16.1.9.2  Products/Solutions/Services offered 192

16.1.9.3  Recent developments           193

16.1.9.3.1                Deals      193

16.1.10   TERRAVERDAE BIOWORKS INC.                194

16.1.10.1                 Business overview 194

16.1.10.2                 Products/Solutions/Services offered 194

16.1.10.3                 Recent developments           195

16.1.10.3.1             Product launches  195

16.1.10.3.2             Deals      195

16.1.10.3.3             Other developments             195

16.2         OTHER PLAYERS              196

16.2.1      CJ CHEILJEDANG CORP.                196

16.2.2      GENECIS BIOINDUSTRIES INC.  196

16.2.3      MANGO MATERIALS       197

16.2.4      COFCO 197

16.2.5      MEDPHA BIOSCIENCE CO., LTD.               198

16.2.6      PAQUES BIOMATERIALS B.V.      198

16.2.7      PRAJ INDUSTRIES            199

16.2.8      PHAXTEC, INC. 199

16.2.9      UNILONG INDUSTRY CO., LTD. 200

16.2.10   MAIP SRL             201

17            RESEARCH METHODOLOGY       202

17.1         RESEARCH DATA              202

17.1.1      SECONDARY DATA          203

17.1.1.1  Key data from secondary sources       203

17.1.2      PRIMARY DATA 203

17.1.2.1  Key data from primary sources           204

17.1.2.2  Key primary participants     204

17.1.2.3  Breakdown of primary interviews      205

17.1.2.4  Key industry insights           205

17.2         MARKET SIZE ESTIMATION         206

17.2.1      BOTTOM-UP APPROACH              206

17.2.2      TOP-DOWN APPROACH                208

17.3         GROWTH FORECAST      208

17.3.1      SUPPLY-SIDE ANALYSIS                 208

17.3.2      DEMAND-SIDE ANALYSIS             209

17.4         DATA TRIANGULATION                210

17.5         FACTOR ANALYSIS          212

17.6         RESEARCH ASSUMPTIONS           212

17.7         RESEARCH LIMITATIONS             213

17.8         RISK ASSESSMENT           213

18            ADJACENT & RELATED MARKETS             214

18.1         INTRODUCTION              214

18.2         LIMITATION      214

18.3         BIOPLASTICS & BIOPOLYMERS MARKET               214

18.3.1      MARKET DEFINITION   214

18.3.2      MARKET OVERVIEW       214

18.4         BIOPLASTICS & BIOPOLYMERS MARKET, BY REGION                 215

18.4.1      EUROPE               215

18.4.2      NORTH AMERICA             216

18.4.3      ASIA PACIFIC     217

18.4.4      MIDDLE EAST & AFRICA                217

18.4.5      SOUTH AMERICA             218

19            APPENDIX           219

19.1         DISCUSSION GUIDE        219

19.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                221

19.3         CUSTOMIZATION OPTIONS        223

19.4         RELATED REPORTS         223

19.5         AUTHOR DETAILS           224

LIST OF TABLES

TABLE 1                NORTH AMERICAN AND EUROPEAN UNION REGULATIONS  37

TABLE 2                CONVENTIONAL PLASTICS: HEALTH CONCERNS         40

TABLE 3                PHA MARKET: PORTER’S FIVE FORCES ANALYSIS            48

TABLE 4                GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2021–2030 (USD BILLION) 48

TABLE 5                PHA MARKET: ROLE IN ECOSYSTEM       54

TABLE 6                AVERAGE SELLING PRICE OF PHA OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 (USD/KG)                55

TABLE 7                AVERAGE SELLING PRICE TREND OF PHA, BY REGION, 2022–2025 (USD/KG)     56

TABLE 8                IMPORT DATA FOR HS CODE 391190-COMPLIANT PRODUCTS,

2020–2024 (USD MILLION)            57

TABLE 9                EXPORT DATA FOR HS CODE 391190-COMPLIANT PRODUCTS,

2020–2024 (USD MILLION)            58

TABLE 10              PHA MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026       59

TABLE 11              PHA MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2025      60

TABLE 12              US ADJUSTED RECIPROCAL TARIFF RATES                 62

TABLE 13              PATENT STATUS: PATENT APPLICATIONS AND GRANTED PATENTS       70

TABLE 14              MAJOR PATENTS FOR PHA          72

TABLE 15              PATENTS BY KANEKA CORPORATION    73

TABLE 16              TOP 10 PATENT OWNERS IN US, 2014–2024                 74

TABLE 17              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  77

TABLE 18              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           77

TABLE 19              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

TABLE 20              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

TABLE 21              SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  79

TABLE 22              GLOBAL STANDARDS IN PHA MARKET  79

TABLE 23              CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PHA MARKET    81

TABLE 24              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%)                 83

TABLE 25              KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 84

TABLE 26              PHA MARKET: UNMET NEEDS IN KEY APPLICATIONS 85

TABLE 27              BACTERIUM STRAINS AND OUTPUT       90

TABLE 28              CURRENT PRODUCTION CAPACITIES (TON)                 93

TABLE 29              UPCOMING PLAYERS     94

TABLE 30              DISCONTINUED OR STALLED PRODUCTION                 95

TABLE 31              PHA MARKET, BY TYPE, 2020–2024 (USD MILLION)            97

TABLE 32              PHA MARKET, BY TYPE, 2025–2030 (USD MILLION)            98

TABLE 33              PHA MARKET, BY TYPE, 2020–2024 (TON)                 98

TABLE 34              PHA MARKET, BY TYPE, 2025–2030 (TON)                 98

TABLE 35              SHORT CHAIN LENGTH: PHA MARKET, BY REGION, 2020–2024 (USD MILLION)          99

TABLE 36              SHORT CHAIN LENGTH: PHA MARKET, BY REGION, 2025–2030 (USD MILLION)          100

TABLE 37              SHORT CHAIN LENGTH: PHA MARKET, BY REGION, 2020–2024 (TON)             100

TABLE 38              SHORT CHAIN LENGTH: PHA MARKET, BY REGION, 2025–2030 (TON)             100

TABLE 39              MEDIUM CHAIN LENGTH: PHA MARKET, BY REGION, 2020–2024 (USD MILLION)          101

TABLE 40              MEDIUM CHAIN LENGTH: PHA MARKET, BY REGION, 2025–2030 (USD MILLION)          102

TABLE 41              MEDIUM CHAIN LENGTH: PHA MARKET, BY REGION, 2020–2024 (TON)             102

TABLE 42              MEDIUM CHAIN LENGTH: PHA MARKET, BY REGION, 2025–2030 (TON)             102

TABLE 43              PHA MARKET, BY PRODUCTION METHOD, 2020–2024 (USD MILLION)            104

TABLE 44              PHA MARKET, BY PRODUCTION METHOD, 2025–2030 (USD MILLION)            104

TABLE 45              PHA MARKET, BY PRODUCTION METHOD, 2020–2024 (TON)               105

TABLE 46              PHA MARKET, BY PRODUCTION METHOD, 2025–2030 (TON)               105

TABLE 47              PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION)            108

TABLE 48              PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION)            109

TABLE 49              PHA MARKET, BY APPLICATION, 2020–2024 (TON)   109

TABLE 50              PHA MARKET, BY APPLICATION, 2025–2030 (TON)   109

TABLE 51              PHA MARKET IN PACKAGING & FOOD APPLICATION, BY REGION,

2020–2024 (USD MILLION)            112

TABLE 52              PHA MARKET IN PACKAGING & FOOD APPLICATION, BY REGION,

2025–2030 (USD MILLION)            112

TABLE 53              PHA MARKET IN PACKAGING & FOOD APPLICATION, BY REGION, 2020–2024 (TON)       112

TABLE 54              PHA MARKET IN PACKAGING & FOOD APPLICATION, BY REGION, 2025–2030 (TON)       113

TABLE 55              PHA MARKET IN BIOMEDICAL APPLICATION, BY REGION,

2020–2024 (USD MILLION)            114

TABLE 56              PHA MARKET IN BIOMEDICAL APPLICATION, BY REGION,

2025–2030 (USD MILLION)            114

TABLE 57              PHA MARKET IN BIOMEDICAL APPLICATION, BY REGION, 2020–2024 (TON)      114

TABLE 58              PHA MARKET IN BIOMEDICAL APPLICATION, BY REGION, 2025–2030 (TON)      115

TABLE 59              PHA MARKET IN AGRICULTURE APPLICATION, BY REGION,

2020–2024 (USD MILLION)            116

TABLE 60              PHA MARKET IN AGRICULTURE APPLICATION, BY REGION,

2025–2030 (USD MILLION)            116

TABLE 61              PHA MARKET IN AGRICULTURE APPLICATION, BY REGION, 2020–2024 (TON)      116

TABLE 62              PHA MARKET IN AGRICULTURE APPLICATION, BY REGION, 2025–2030 (TON)      117

TABLE 63              PHA MARKET IN OTHER APPLICATIONS, BY REGION, 2020–2024 (USD MILLION)          118

TABLE 64              PHA MARKET IN OTHER APPLICATIONS, BY REGION, 2025–2030 (USD MILLION)          118

TABLE 65              PHA MARKET IN OTHER APPLICATIONS, BY REGION, 2020–2024 (TON)             118

TABLE 66              PHA MARKET IN OTHER APPLICATIONS, BY REGION, 2025–2030 (TON)             119

TABLE 67              PHA MARKET, BY REGION, 2020–2024 (USD MILLION)            121

TABLE 68              PHA MARKET, BY REGION, 2025–2030 (USD MILLION)            122

TABLE 69              PHA MARKET, BY REGION, 2020–2024 (TON)                 122

TABLE 70              PHA MARKET, BY REGION, 2025–2030 (TON)                 122

TABLE 71              EUROPE: PHA MARKET, BY TYPE, 2020–2024 (USD MILLION) 124

TABLE 72              EUROPE: PHA MARKET, BY TYPE, 2025–2030 (USD MILLION) 124

TABLE 73              EUROPE: PHA MARKET, BY TYPE, 2020–2024 (TON)   125

TABLE 74              EUROPE: PHA MARKET, BY TYPE, 2025–2030 (TON)   125

TABLE 75              EUROPE: PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION)       125

TABLE 76              EUROPE: PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION)       125

TABLE 77              EUROPE: PHA MARKET, BY APPLICATION, 2020–2024 (TON)          126

TABLE 78              EUROPE: PHA MARKET, BY APPLICATION, 2025–2030 (TON)          126

TABLE 79              EUROPE: PHA MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 126

TABLE 80              EUROPE: PHA MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 127

TABLE 81              EUROPE: PHA MARKET, BY COUNTRY, 2020–2024 (TON)   127

TABLE 82              EUROPE: PHA MARKET, BY COUNTRY, 2025–2030 (TON)   127

TABLE 83              GERMANY: PHA MARKET, 2020–2024         128

TABLE 84              GERMANY: PHA MARKET, 2025–2030         128

TABLE 85              UK: PHA MARKET, 2020–2024        129

TABLE 86              UK: PHA MARKET SIZE, 2025–2030              129

TABLE 87              FRANCE: PHA MARKET, 2020–2024             129

TABLE 88              FRANCE: PHA MARKET SIZE, 2025–2030   129

TABLE 89              ITALY: PHA MARKET, 2020–2024 130

TABLE 90              ITALY: PHA MARKET SIZE, 2025–2030       130

TABLE 91              NORTH AMERICA: PHA MARKET, BY TYPE, 2020–2024 (USD MILLION)       132

TABLE 92              NORTH AMERICA: PHA MARKET, BY TYPE, 2025–2030 (USD MILLION)       132

TABLE 93              NORTH AMERICA: PHA MARKET, BY TYPE, 2020–2024 (TON)          132

TABLE 94              NORTH AMERICA: PHA MARKET, BY TYPE, 2025–2030 (TON)          132

TABLE 95              NORTH AMERICA: PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION)              133

TABLE 96              NORTH AMERICA: PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION)              133

TABLE 97              NORTH AMERICA: PHA MARKET, BY APPLICATION, 2020–2024 (TON)                133

TABLE 98              NORTH AMERICA: PHA MARKET, BY APPLICATION, 2025–2030 (TON)                134

TABLE 99              NORTH AMERICA: PHA MARKET, BY COUNTRY, 2020–2024 (USD MILLION)            134

TABLE 100            NORTH AMERICA: PHA MARKET, BY COUNTRY, 2025–2030 (USD MILLION)            134

TABLE 101            NORTH AMERICA: PHA MARKET, BY COUNTRY, 2020–2024 (TON)               135

TABLE 102            NORTH AMERICA: PHA MARKET, BY COUNTRY, 2025–2030 (TON)               135

TABLE 103            US: PHA MARKET, 2020–2024        136

TABLE 104            US: PHA MARKET, 2025–2030        136

TABLE 105            CANADA: PHA MARKET, 2020–2024            136

TABLE 106            CANADA: PHA MARKET, 2025–2030            137

TABLE 107            MEXICO: PHA MARKET, 2020–2024             137

TABLE 108            MEXICO: PHA MARKET, 2025–2030             137

TABLE 109            ASIA PACIFIC: PHA MARKET, BY TYPE, 2020–2024 (USD MILLION) 139

TABLE 110            ASIA PACIFIC: PHA MARKET, BY TYPE, 2025–2030 (USD MILLION) 139

TABLE 111            ASIA PACIFIC: PHA MARKET, BY TYPE, 2020–2024 (TON)   139

TABLE 112            ASIA PACIFIC: PHA MARKET, BY TYPE, 2025–2030 (TON)   139

TABLE 113            ASIA PACIFIC: PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION)            140

TABLE 114            ASIA PACIFIC: PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION)            140

TABLE 115            ASIA PACIFIC: PHA MARKET, BY APPLICATION, 2020–2024 (TON)               140

TABLE 116            ASIA PACIFIC: PHA MARKET, BY APPLICATION, 2025–2030 (TON)               141

TABLE 117            ASIA PACIFIC: PHA MARKET, BY COUNTRY, 2020–2024 (USD MILLION)            141

TABLE 118            ASIA PACIFIC: PHA MARKET, BY COUNTRY, 2025–2030 (USD MILLION)            141

TABLE 119            ASIA PACIFIC: PHA MARKET, BY COUNTRY, 2020–2024 (TON)               142

TABLE 120            ASIA PACIFIC: PHA MARKET, BY COUNTRY, 2025–2030 (TON)               142

TABLE 121            CHINA: PHA MARKET, 2020–2024                143

TABLE 122            CHINA: PHA MARKET, 2025–2030                143

TABLE 123            INDIA: PHA MARKET, 2020–2024 143

TABLE 124            INDIA: PHA MARKET, 2025–2030 143

TABLE 125            JAPAN: PHA MARKET, 2020–2024                 144

TABLE 126            JAPAN: PHA MARKET, 2025–2030                 144

TABLE 127            MALAYSIA: PHA MARKET, 2020–2024        145

TABLE 128            MALAYSIA: PHA MARKET, 2025–2030        145

TABLE 129            SOUTH KOREA: PHA MARKET, 2020–2024                 146

TABLE 130            SOUTH KOREA: PHA MARKET, 2025–2030                 146

TABLE 131            REST OF THE WORLD: PHA MARKET, BY TYPE, 2020–2024 (USD MILLION)            146

TABLE 132            REST OF THE WORLD: PHA MARKET, BY TYPE, 2025–2030 (USD MILLION)            147

TABLE 133            REST OF THE WORLD: PHA MARKET, BY TYPE, 2020–2024 (TON)               147

TABLE 134            REST OF THE WORLD: PHA MARKET, BY TYPE, 2025–2030 (TON)               147

TABLE 135            REST OF THE WORLD: PHA MARKET, BY APPLICATION, 2020–2024 (USD MILLION)              147

TABLE 136            REST OF THE WORLD: PHA MARKET, BY APPLICATION, 2025–2030 (USD MILLION)              148

TABLE 137            REST OF THE WORLD: PHA MARKET, BY APPLICATION, 2020–2024 (TON)                148

TABLE 138            REST OF THE WORLD: PHA MARKET, BY APPLICATION, 2025–2030 (TON)                148

TABLE 139            REST OF THE WORLD: PHA MARKET, BY REGION, 2020–2024 (USD MILLION)          149

TABLE 140            REST OF THE WORLD: PHA MARKET, BY REGION, 2025–2030 (USD MILLION)          149

TABLE 141            REST OF THE WORLD: PHA MARKET, BY REGION, 2020–2024 (TON)             149

TABLE 142            REST OF THE WORLD: PHA MARKET, BY REGION, 2025–2030 (TON)             149

TABLE 143            SOUTH AMERICA: PHA MARKET, 2020–2024                 150

TABLE 144            SOUTH AMERICA: PHA MARKET, 2025–2030                 150

TABLE 145            MIDDLE EAST & AFRICA: PHA MARKET, 2020–2024        151

TABLE 146            MIDDLE EAST & AFRICA: PHA MARKET, 2025–2030        151

TABLE 147            PHA MARKET: STRATEGIES ADOPTED BY KEY MANUFACTURERS,

JANUARY 2020–SEPTEMBER 2025                152

TABLE 148            PHA MARKET: DEGREE OF COMPETITION, 2024                 154

TABLE 149            PHA MARKET: REGION FOOTPRINT        160

TABLE 150            PHA MARKET: TYPE FOOTPRINT              161

TABLE 151            PHA MARKET: APPLICATION FOOTPRINT                 162

TABLE 152            PHA MARKET: DETAILED LIST OF KEY STARTUPS/SMES              164

TABLE 153            PHA MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES              165

TABLE 154            PHA MARKET: PRODUCT LAUNCHES, JANUARY 2020–SEPTEMBER 2025   167

TABLE 155            PHA MARKET: DEALS, JANUARY 2020– SEPTEMBER 2025              168

TABLE 156            PHA MARKET: EXPANSIONS, JANUARY 2020– SEPTEMBER 2025              171

TABLE 157            PHA MARKET: OTHER DEVELOPMENTS, JANUARY 2020–SEPTEMBER 2025                172

TABLE 158            TEKNOR APEX: COMPANY OVERVIEW   173

TABLE 159            TEKNOR APEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED    173

TABLE 160            TEKNOR APEX: DEALS   174

TABLE 161            KANEKA CORPORATION: COMPANY OVERVIEW                 175

TABLE 162            KANEKA CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED    176

TABLE 163            KANEKA CORPORATION: DEALS               177

TABLE 164            KANEKA CORPORATION: EXPANSIONS 177

TABLE 165            ECOMANN BIOTECHNOLOGY CO. LTD: COMPANY OVERVIEW   179

TABLE 166            ECOMANN BIOTECHNOLOGY CO. LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED    179

TABLE 167            RWDC INDUSTRIES: COMPANY OVERVIEW                 181

TABLE 168            RWDC INDUSTRIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED    181

TABLE 169            RWDC INDUSTRIES: DEALS         181

TABLE 170            RWDC INDUSTRIES: OTHER DEVELOPMENTS                 182

TABLE 171            BLUEPHA CO. LTD.: COMPANY OVERVIEW                 184

TABLE 172            BLUEPHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    184

TABLE 173            BLUEPHA CO. LTD.: PRODUCT LAUNCHES                 185

TABLE 174            BLUEPHA CO. LTD.: DEALS         185

TABLE 175            BLUEPHA CO. LTD.: EXPANSIONS            186

TABLE 176            NEWLIGHT TECHNOLOGIES, INC.: COMPANY OVERVIEW          187

TABLE 177            NEWLIGHT TECHNOLOGIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    187

TABLE 178            NEWLIGHT TECHNOLOGIES, INC.: DEALS                 187

TABLE 179            NEWLIGHT TECHNOLOGIES: EXPANSIONS                 188

TABLE 180            NINGBO TIANAN BIOMATERIALS CO., LTD.: COMPANY OVERVIEW   190

TABLE 181            NINGBO TIANAN BIOMATERIALS CO., LTD.: PRODUCTS/SOLUTIONS/

SERVICES OFFERED        190

TABLE 182            BIOMER: COMPANY OVERVIEW 191

TABLE 183            BIOMER: PRODUCTS/SOLUTIONS/SERVICES OFFERED             191

TABLE 184            BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD: COMPANY OVERVIEW        192

TABLE 185            BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD: PRODUCTS/SOLUTIONS/ SERVICES OFFERED        192

TABLE 186            BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD: DEALS        193

TABLE 187            TERRAVERDAE BIOWORKS INC.: COMPANY OVERVIEW          194

TABLE 188            TERRAVERDAE BIOWORKS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    194

TABLE 189            TERRAVERDAE BIOWORKS INC.: PRODUCT LAUNCHES          195

TABLE 190            TERRAVERDAE BIOWORKS INC.: DEALS 195

TABLE 191            TERRAVERDAE BIOWORKS INC.: OTHER DEVELOPMENTS              195

TABLE 192            CJ CHEILJEDANG CORP.: COMPANY OVERVIEW                 196

TABLE 193            GENECIS BIOINDUSTRIES INC.: COMPANY OVERVIEW          196

TABLE 194            MANGO MATERIALS: COMPANY OVERVIEW                 197

TABLE 195            COFCO: COMPANY OVERVIEW  197

TABLE 196            MEDPHA BIOSCIENCE CO., LTD.: COMPANY OVERVIEW          198

TABLE 197            PAQUES BIOMATERIALS B.V.: COMPANY OVERVIEW          198

TABLE 198            PRAJ INDUSTRIES: COMPANY OVERVIEW                 199

TABLE 199            PHAXTEC, INC.: COMPANY OVERVIEW  199

TABLE 200            UNILONG INDUSTRY CO., LTD.: COMPANY OVERVIEW          200

TABLE 201            MAIP SRL: COMPANY OVERVIEW              201

TABLE 202            PHA MARKET: RISK ASSESSMENT             213

TABLE 203            BIOPLASTICS & BIOPOLYMERS MARKET, BY REGION, 2019–2023 (USD MILLION)          215

TABLE 204            BIOPLASTICS & BIOPOLYMERS MARKET, BY REGION, 2024–2029 (USD MILLION)          215

TABLE 205            EUROPE: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY,

2019–2023 (USD MILLION)            215

TABLE 206            EUROPE: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            216

TABLE 207            NORTH AMERICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY,

2019–2023 (USD MILLION)            216

TABLE 208            NORTH AMERICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            216

TABLE 209            ASIA PACIFIC: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY,

2019–2023 (USD MILLION)            217

TABLE 210            ASIA PACIFIC: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            217

TABLE 211            MIDDLE EAST & AFRICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2019–2023 (USD MILLION)            217

TABLE 212            MIDDLE EAST & AFRICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)            218

TABLE 213            SOUTH AMERICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY,

2019–2023 (USD MILLION)            218

TABLE 214            SOUTH AMERICA: BIOPLASTICS & BIOPOLYMERS MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            218

LIST OF FIGURES

FIGURE 1              PHA MARKET SEGMENTATION AND REGIONAL SCOPE  23

FIGURE 2              KEY INSIGHTS AND MARKET HIGHLIGHTS                 28

FIGURE 3              GLOBAL PHA MARKET, 2025–2030              28

FIGURE 4              MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHA MARKET (2020–2025)        29

FIGURE 5              DISRUPTIVE TRENDS IMPACTING GROWTH OF PHA MARKET     30

FIGURE 6              HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PHA MARKET, 2024            30

FIGURE 7              EUROPE TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       31

FIGURE 8              HIGH DEMAND FROM PACKAGING & FOOD SERVICES APPLICATIONS

TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS              33

FIGURE 9              PACKAGING & FOOD SERVICES APPLICATION ACCOUNTED FOR

LARGEST MARKET SHARE IN 2024             34

FIGURE 10            SHORT CHAIN LENGTH SEGMENT DOMINATED PHA MARKET IN 2024      34

FIGURE 11            ITALY TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD         35

FIGURE 12            PHA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES     36

FIGURE 13            SHORTCOMINGS OF NON-BIODEGRADABLE WASTE DISPOSAL METHODS     39

FIGURE 14            PHA MARKET: PORTER’S FIVE FORCES ANALYSIS            46

FIGURE 15            PHA MARKET: SUPPLY CHAIN ANALYSIS                 51

FIGURE 16            PHA MARKET: KEY PARTICIPANTS IN ECOSYSTEM       53

FIGURE 17            PHA MARKET: ECOSYSTEM ANALYSIS    53

FIGURE 18            AVERAGE SELLING PRICE OF PHA OFFERED BY KEY PLAYERS,

BY APPLICATION, 2024  55

FIGURE 19            AVERAGE SELLING PRICE TREND OF PHA, BY REGION, 2022–2025           56

FIGURE 20            IMPORT SCENARIO FOR HS CODE 391190-COMPLIANT PRODUCTS,

BY KEY COUNTRIES, 2020–2024   57

FIGURE 21            EXPORT SCENARIO FOR HS CODE 391190-COMPLIANT PRODUCTS,

BY KEY COUNTRIES, 2020–2024   58

FIGURE 22            TREND/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           60

FIGURE 23            PATENTS REGISTERED, 2014–2024             71

FIGURE 24            LIST OF MAJOR PATENTS FOR PHA         71

FIGURE 25            LEGAL STATUS OF PATENTS FILED IN PHA MARKET               74

FIGURE 26            MAXIMUM PATENTS FILED IN JURISDICTION OF US    75

FIGURE 27            IMPACT OF AI/GEN AI ON PHA MARKET                 75

FIGURE 28            PHA MARKET: DECISION-MAKING FACTORS                 82

FIGURE 29            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION        83

FIGURE 30            KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 84

FIGURE 31            ADOPTION BARRIERS & INTERNAL CHALLENGES    85

FIGURE 32            PROCESS FLOW OF PHA PRODUCTION 87

FIGURE 33            SUGAR SUBSTRATES FOR PHA PRODUCTION                 88

FIGURE 34            HYDROCARBON SUBSTRATES   89

FIGURE 35            EXTRACTION PROCESS FLOW   92

FIGURE 36            SHORT CHAIN LENGTH SEGMENT TO HOLD LARGEST SHARE OF

PHA MARKET IN 2025      97

FIGURE 37            SUGAR FERMENTATION SEGMENT TO HOLD LARGEST SHARE OF

PHA MARKET DURING FORECAST PERIOD          104

FIGURE 38            PACKAGING & FOOD SERVICES TO DOMINATE PHA MARKET DURING

FORECAST PERIOD         108

FIGURE 39            EUROPE TO LEAD PHA MARKET BETWEEN 2025 AND 2030              121

FIGURE 40            EUROPE: PHA MARKET SNAPSHOT          124

FIGURE 41            NORTH AMERICA: PHA MARKET SNAPSHOT                 131

FIGURE 42            ASIA PACIFIC: PHA MARKET SNAPSHOT                 138

FIGURE 43            PHA MARKET SHARE ANALYSIS, 2024      154

FIGURE 44            PHA MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 (USD MILLION)        156

FIGURE 45            PHA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024       158

FIGURE 46            PHA MARKET: COMPANY FOOTPRINT   159

FIGURE 47            PHA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                164

FIGURE 48            PHA MARKET: BRAND COMPARISON      165

FIGURE 49            PHA MARKET: EV/EBITDA OF KEY MANUFACTURERS           166

FIGURE 50            PHA MARKET: ENTERPRISE VALUATION (EV) OF KEY PLAYERS (USD BILLION)               167

FIGURE 51            KANEKA CORPORATION: COMPANY SNAPSHOT                 176

FIGURE 52            PHA MARKET: RESEARCH DESIGN           202

FIGURE 53            MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (SUPPLY SIDE): COLLECTIVE MARKET SHARE OF KEY PLAYERS     206

FIGURE 54            MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 – BOTTOM-UP

(SUPPLY SIDE): COLLECTIVE REVENUE OF ALL PRODUCTS                 207

FIGURE 55            MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 3 – BOTTOM-UP

(DEMAND SIDE)               207

FIGURE 56            MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 3 – TOP-DOWN          208

FIGURE 57            MARKET CAGR PROJECTIONS FROM SUPPLY SIDE      209

FIGURE 58            MARKET GROWTH PROJECTIONS FROM DEMAND-SIDE DRIVERS

AND OPPORTUNITIES   210

FIGURE 59            PHA MARKET: DATA TRIANGULATION 211